Citation Impact
Citing Papers
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
2003
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
2002
Circulatory function and hepatorenal syndrome in cirrhosis†
2005
Acute kidney injury
2012 Standout
Liver fibrosis
2005 Standout
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
2007
Human serum albumin: From bench to bedside
2011
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
2017 Standout
The effect of 1 month of therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot study
2009
Management of adult patients with ascites due to cirrhosis†
2004
Descending control of pain
2002 Standout
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
2002
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
2002
Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study
2013
Diagnosis and treatment of acute renal failure in patients with cirrhosis
2007
Albumin–drug interaction and its clinical implication
2013 Standout
Renal Failure in Cirrhosis
2009
Seasonal changes in plasma glucocorticoid concentrations in free-living vertebrates
2002 Standout
Acute Kidney Injury: New Concepts
2008
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study
2002
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Vascular disorders of the liver # †
2008 Standout
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials
2010
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
2003
Acute kidney injury
2019 Standout
Management of Cirrhosis and Ascites
2004
Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
2007
Daily and Seasonal Variation in Response to Stress in Captive Starlings (Sturnus vulgaris): Corticosterone
2000
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome
2007
Hepatorenal Disorders
2015
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial
2009
Management of adult patients with ascites caused by cirrhosis†
1998
Acute kidney injury in cirrhosis
2008
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
2015
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost
2005
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
2007
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice
2012
Advances in alcoholic liver disease
2003
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Albumin Therapy in Clinical Practice
2005
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
2008
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
2011
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
High–Dose Pulse Versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome
2003
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study
2000
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
2014
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Alcoholic Hepatitis
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Portal Hypertension and Its Complications
2008
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
2017
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study
2016
Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival
2016
Works of Roberta Volpin being referenced
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
1999
Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites
1998
Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: A controlled clinical trial
2002
Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites
2000